On March 17, 2016, Jonckers, Tim Hugo Maria; Mc Gowan, David Craig; Raboisson, Pierre Jean-Marie Bernard; Embrechts, Werner Constant Johan; Guillemont, Jerome Emile Georges published a patent.HPLC of Formula: 89792-07-4 The title of the patent was Preparation of pyrrolopyrimidines for the treatment of influenza virus infection. And the patent contained the following:
Title compounds I [X = N or C (optionally substituted with -CN, -CF3, -CONH2, etc.); R1 = H or CH3; R2 = H or NH2; R3 = carboxy-substituted alkyl, carboxy-substituted cycloalkyl, -N-alkylsulfone, etc.; or stereoisomeric forms, pharmaceutically acceptable salts, solvates, or polymorphs thereof] were prepared For example, reaction of 2,4-dichloro-5-fluoropyrimidine with cis-N-(3-aminocyclohexyl)pyrrolidine-1-carboxamide/DIPEA followed by Pd(PPh3)4-catalyzed coupling reaction with 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine and deprotection using NaOMe afforded compound II. In anti-influenza activity test against A/Taiwan/1/86 (H1N1) virus, IC50 value of II was 0.005 μM. The experimental process involved the reaction of 2-Methyl-7H-pyrrolo[2,3-d]pyrimidine(cas: 89792-07-4).HPLC of Formula: 89792-07-4
The Article related to pyrrolopyrimidine preparation influenza virus infection treatment, Heterocyclic Compounds (More Than One Hetero Atom): Pyrimidines and Quinazolines and other aspects.HPLC of Formula: 89792-07-4
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia